Analysis of Hepatitis B Virus Integration Reveals New Insights of Oncogenic Mechanism in Dysplastic Liver Nodule
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.70755 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Xi Zeng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Agricultural Bioinformatic, 3D Genomics Research Center, College of Informatics, Huazhong Agricultural University, Wuhan, Chi…. Hauptthemen laut MEDLINE: Virus Integration, Hepatitis B virus, Liver Neoplasms, Liver Cirrhosis. Die Arbeit nennt 74 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Shanghai Rising Star Program.
Abstract (Originalsprache)
Dysplastic nodules (DN) are precursors to cirrhosis‐associated malignancy, and the HBV DNA integration in the human genome plays a critical role in tumorigenesis. However, the precise relationship between DN and HBV integration remains unclear. We performed HBV‐capture sequencing on 19 cirrhosis patients with HBV infection (DN, 10; RN, 9), out of which 10 subjects (DN, 9; RN, 1) underwent RNA sequencing. In total, 1936 and 1450 HBV integration sites were identified in the DN and RN samples, respectively. The number of HBV integration sites in DN correlated with nodule size. Breakpoints in HBV genome were concentrated within 100 bps toward the 5′ or 3′ end of involved HBV genes. Furthermore, integration numbers also positively correlated with number of point mutations in DN samples. We identified 53 and 29 recurrent genes containing HBV integrations in ≥ 2 samples in DN and RN samples, respectively. Higher clonality was observed for HBV integrations in recurrent genes than other HBV‐integrated genes. The HBV integrations in recurrent genes were predominantly located in intron regions. Notably, among those recurrently HBV‐integrated genes in DN samples, SCHIP1 , ZDHHC14 , YPEL2 , RABGAP1L , and SOX5 displayed significant expression alterations. Moreover, clinical indicators revealed significant prolongation of prothrombin time in two DN patients with HBV integrations in SCHIP1 and ZDHHC14 . As a new insight regarding HBV integrations in DN stage, our findings suggest a possible role of HBV integration in the transformation of DN to early‐stage liver cancer by affecting the expression of key genes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory of Agricultural Bioinformatic, 3D Genomics Research Center, College of Informatics, Huazhong Agricultural University, Wuhan, China.
- Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
ORCID-Profile: Xi Zeng
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Shanghai Rising Star Program
- Qihang Project of Naval Medical University
- Mengchao Program of Eastern Hepatobiliary Surgery Hospital
- Shanghai "Rising Stars of Medical Talents" Youth Development Program
- EHBH Top-Notch Talent Program
Zitieren
APA
Zeng, X., Liu, H., Xu, Z., Rao, X., Wang, Y., Peng, F., Dong, W., Wang, Z., Wang, Z., Gu, X., Liu, F., Li, G., Zhou, W., & Zhao, L. (2026). Analysis of Hepatitis B Virus Integration Reveals New Insights of Oncogenic Mechanism in Dysplastic Liver Nodule. Journal of Medical Virology. https://doi.org/10.1002/jmv.70755
Vancouver
Zeng X, Liu H, Xu Z, Rao X, Wang Y, Peng F, et al. Analysis of Hepatitis B Virus Integration Reveals New Insights of Oncogenic Mechanism in Dysplastic Liver Nodule. Journal of Medical Virology. 2026. doi:10.1002/jmv.70755
BibTeX
@article{Zeng2026,
author = {Zeng, Xi and Liu, Hui and Xu, Zheqi and Rao, Xinjie and Wang, Yuyouye and Peng, Fang and Dong, Wei and Wang, Ziying and Wang, Zhenguang and Gu, Xing and Liu, Fuchen and Li, Guoliang and Zhou, Weiping and Zhao, Linghao},
title = {Analysis of Hepatitis B Virus Integration Reveals New Insights of Oncogenic Mechanism in Dysplastic Liver Nodule},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.70755}
}
EUVIMED